We are celebrating 20 years of science impact
Solving the mysteries of bioscience
Foundational Science Fuels Breakthroughs
Inspiring Next-Generation Scientists
Hear from Allen Institute for Immunology scientists and their collaborators from University of California, San Diego and the University of Colorado at the American College of Rheumatology (ACR) annual meeting, November 10-15 at the San Diego Convention Center in San Diego.
San Diego Convention Center
Doctors, Graduate, Health Care Providers, Postdocs
The Allen Institute for Immunology is collaborating with the University of California-San Diego, the University of Colorado, and the Benaroya Research Institute to understand why some people develop rheumatoid arthritis (RA).
Additionally, the Allen Institute for Immunology will be presenting work on a separate collaboration with the University of Colorado studying serum samples from the Department of Defense Serum Repository to better understand the evolution from pre-clinical to clinical RA.
Adam Savage, Ph.D., an assistant investigator at the Allen Institute for Immunology is presenting a poster on: “Expansion of Atypical B Cells Accompanies Rheumatoid Arthritis-like Immune Dysregulation in ACPA+ At-risk Individuals.”
Location: (2095-2140) RA – Diagnosis, Manifestations, and Outcomes Poster III, Poster Hall
Poster Session: C
Abstract Number: 2124
Rachna Talluri, M.D., University of Colorado, is presenting a poster on: “Sputum Citrullinated Proteins and Sputum Anti-Cit-S100A8/A9 IgG Antibodies Are Increased in Serum Anti-CCP-IgG Positive Individuals Who Developed RA.”
Abstract Number: 1742
Location: (1734–1775) RA – Etiology and Pathogenesis Poster, Poster Hall
Cong Liu, Ph.D., University of California San Diego, is presenting on: “Integrated Single Cell Multi-omics Analysis in At-risk for Future Rheumatoid Arthritis (RA) and Early RA Reveals Shared Transcription Factor Profiles in Multiple Cell Lineages.”
Samir Rachid Zaim, Ph.D., a biostatistician at the Allen Institute for Immunology, is presenting a talk on: “Proteomic Signatures in Pre-Rheumatoid Arthritis Suggest Evolving Biological Pathways in Different Stages of Disease Development That May Inform Prediction and Prevention Strategies.”